Ropes & Gray Earns Worldwide Rankings in Chambers Global 2022
The 2022 edition of Chambers Global acknowledged Ropes & Gray as a leading international law firm in 48 categories across the Asia-Pacific, Europe, Latin America, and the United States, and recognized the firm’s lawyers with 63 individual rankings. The firm secured seven new practice rankings.
Global-wide
- Banking & Finance
- Corporate Investigations/Anti-Corruption
- Investment Funds: Hedge Funds
- Investment Funds: Private Equity: Fund Formation
- Life Sciences
- Private Equity
Asia-Pacific
- Corporate/M&A: Private Equity
- Intellectual Property
- Investment Funds: Private Equity
- Life Sciences
China
- Banking & Finance: Leveraged & Acquisition Finance (International Firms)
- Corporate Investigations/Anti-Corruption (International Firms)
- Corporate/M&A: Highly Regarded (International Firms)
- Intellectual Property (International Firms)
- International & Cross-Border Transactions (International Firms)
- Investment Funds: Private Equity (International Firms)
India
- Corporate/M&A (International Firms)
Japan
- Banking & Finance: International Firms
- Corporate/M&A: International Firms
Latin America-wide
- Corporate Investigations: International Firms
South Korea
- Corporate/M&A: International Firms
- Intellectual Property: International Firms
- International & Cross-Border Transactions: International Firms
United Kingdom
- Tax
USA
- Banking & Finance
- Bankruptcy/Restructuring: The Elite
- Capital Markets: Equity: Issuer Representation
- Capital Markets: Equity: Manager Representation
- Competition/Antitrust
- Corporate Crime & Investigations
- Corporate/M&A (International & Cross-Border)
- FCPA
- Finance & Capital Markets (International & Cross-Border)
- Hedge Funds
- Investigations & Enforcement (International & Cross-Border)
- Investment Funds & Asset Management (International & Cross-Border)
- Investment Funds: Investor Representation
- Investment Funds: Regulatory & Compliance
- Life Sciences & Pharmaceutical Sector (International & Cross-Border)
- Life Sciences: Regulatory/Compliance
- Privacy & Data Security: The Elite
- Private Equity: Buyouts: High-End Capability
- Private Equity: Buyouts: Mid-Market
- Private Equity: Fund Formation
- Registered Funds
- SPACs
- Tax: Corporate & Finance